Automated description from the Alliance of Genome Resources (Release 7.5.0)
Enables (R)-carnitine transmembrane transporter activity. Involved in several processes, including (R)-carnitine transmembrane transport; response to tumor necrosis factor; and response to type II interferon. Acts upstream of or within several processes, including adult heart development; carnitine metabolic process; and carnitine transport. Located in apical plasma membrane and brush border membrane. Is expressed in several structures, including liver; metanephros; nasal cavity mucosa; spleen; and testis. Used to study systemic primary carnitine deficiency disease. Human ortholog(s) of this gene implicated in Crohn's disease; cardiomyopathy; inherited metabolic disorder; and systemic primary carnitine deficiency disease. Orthologous to human SLC22A5 (solute carrier family 22 member 5).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.